Nu-Med Plus (NUMD) Cash from Operations Growth (1y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.69% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -84.38% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.43% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 185.96% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 16.00% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.60% |
| 10 | Nu-Med Plus | - | - | - | -2,001.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,001.56% |
| Dec 31, 2024 | 61.05% |
| Jun 30, 2024 | 89.97% |
| Mar 31, 2024 | 97.77% |
| Dec 31, 2023 | 82.47% |
| Sep 30, 2023 | -3,104.62% |
| Jun 30, 2023 | -809.42% |
| Mar 31, 2023 | -66.14% |
| Dec 31, 2022 | -21.17% |
| Sep 30, 2022 | 101.53% |
| Jun 30, 2022 | 96.18% |
| Mar 31, 2022 | 84.68% |
| Dec 31, 2021 | 71.70% |
| Sep 30, 2021 | 59.42% |
| Jun 30, 2021 | 54.91% |
| Mar 31, 2021 | 16.75% |
| Dec 31, 2020 | 42.85% |
| Sep 30, 2020 | -33.87% |
| Jun 30, 2020 | -22.25% |
| Mar 31, 2020 | 61.41% |
| Dec 31, 2019 | 13.02% |
| Sep 30, 2019 | 47.20% |
| Jun 30, 2019 | -21.06% |
| Mar 31, 2019 | -201.75% |
| Dec 31, 2018 | -2.98% |
| Sep 30, 2018 | -11.81% |
| Jun 30, 2018 | -11.11% |
| Mar 31, 2018 | -10.62% |
| Dec 31, 2017 | -237.46% |
| Sep 30, 2017 | -228.21% |
| Jun 30, 2017 | -79.88% |
| Mar 31, 2017 | -47.03% |
| Dec 31, 2016 | 13.20% |
| Sep 30, 2016 | 0.89% |
| Jun 30, 2016 | 5.67% |
| Mar 31, 2016 | -16.11% |
| Dec 31, 2015 | -29.43% |
| Sep 30, 2015 | -11.37% |
| Jun 30, 2015 | -24.60% |
| Mar 31, 2015 | 1.34% |
| Sep 30, 2014 | 7.71% |
| Jun 30, 2014 | -28.55% |
| Mar 31, 2014 | -21.50% |
| Sep 30, 2013 | -42.87% |
| Jun 30, 2013 | -78.09% |
| Mar 31, 2013 | -22.32% |